Skip to main content

Apnimed, Inc.

corporate_fare Company Profile

Apnimed, Inc.

APMD·NASDAQ·Life Sciences·CIK 0001745648

Apnimed Inc. is a clinical pharmaceutical company that develops and manufactures novel oral therapies addressing the neurobiology of sleep-related breathing diseases in global markets. The company's primary product is AD109, an oral therapy specifically designed to treat obstructive sleep apnea (OSA). AD109 targets the underlying neuromuscular dysfunction associated with OSA. Apnimed Inc. was incorporated in 2017 and operates from its base in Cambridge, Massachusetts.

Apnimed, Inc. (NASDAQ:APMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 9 items for APMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 9 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for APMD spans 10-Q, 8-K.

Recent high-impact activity:

  • Apnimed 10-Q: $29.5M Q3 Loss, $351.8M Cash, and a Material Weakness in Controls
  • Apnimed Posts $29.5M Q3 Loss; $351.8M Cash Funds Launch Into Q2 2028
  • Apnimed Posts $29.5M Q3 Loss as Launch Costs Surge Ahead of Feb 2027 PDUFA
  • Apnimed Restates Q2 2026 Financials After SASS Gain Misclassification
  • Apnimed Q2: $125.9M Net Income Driven by One-Time Gains; Material Weakness in ICFR Disclosed

Short Interest & Short Volume

4.54 days to cover

FINRA reported short interest of 1,586,895 shares in APMD as of the October 30, 2026 settlement, a 12.0% decrease from the prior period — about 4.5 days to cover at its recent average daily volume. On November 20, 2026, 66.7% of APMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,586,895 shares as of October 30, 2026
Change vs prior period▼ 12.0%
Days to cover4.54 at avg daily volume of 349,282
Daily short volume (FINRA facilities)66.7% of 90,277 shares on November 20, 2026
5-day average short volume73.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for APMD, detected from its recent SEC filings · based on capital-structure filings through 2026-07-31.

1 recent capital raise

IPO Terms Finalized · Pricing Previously Announced

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$16.09
52-week range · as of 2026-11-16 $13.88 – $35.29
Market cap
$669.84M
Volume
248.6K (0.7× avg)
3-mo avg 377.6K
Live data · 2026-11-22 12:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed APMD - Latest Insights

APMD
Nov 16, 2026, 8:09 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $16.92
Real-time Price: $16.09 info
Change: -$0.830 (-5%) info
Market Cap: $669.839M info
APMD
Nov 16, 2026, 8:04 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.92
Real-time Price: $16.09 info
Change: -$0.830 (-5%) info
Market Cap: $669.839M info
APMD
Nov 16, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $16.92
Real-time Price: $16.09 info
Change: -$0.830 (-5%) info
Market Cap: $669.839M info
APMD
Nov 13, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.92
Real-time Price: $16.09 info
Change: -$0.830 (-5%) info
Market Cap: $669.839M info
APMD
Sep 08, 2026, 5:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $28.79
Real-time Price: $16.09 info
Change: -$12.70 (-44%) info
Market Cap: $669.839M info
APMD
Sep 08, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.79
Real-time Price: $16.09 info
Change: -$12.70 (-44%) info
Market Cap: $669.839M info
APMD
Sep 08, 2026, 4:39 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $28.79
Real-time Price: $16.09 info
Change: -$12.70 (-44%) info
Market Cap: $669.839M info
APMD
Aug 03, 2026, 4:35 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $25.00
Real-time Price: $16.09 info
Change: -$8.91 (-36%) info
Market Cap: $669.839M info
APMD
Jul 31, 2026, 12:44 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $18.95
Real-time Price: $16.09 info
Change: -$2.86 (-15%) info
Market Cap: $669.839M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets